Correlation of liver imaging and transient elastography among patients with hepatitis C at a safety net hospital

Table 1 Demographics of patients with chronic hepatitis C virus with transient elastography, n (%)

Variables	Patients (n = 959)
Age (years), mean ± SD	64.05 ± 9.81
Gender
Male	622 (64.9)
Female	337 (35.1)
Race
African American	780 (81.3)
White	146 (15.2)
Hispanic	16 (1.7)
Asian	4 (0.4)
American Indian and Alaskan Native	3 (0.3)
BMI (kg/m²), mean ± SD	27.13 ± 5.89
BMI categories
< 25	365 (38.1)
25-30	326 (34)
30-35	163 (17)
35-40	79 (8.2)
> 40	26 (2.7)
Alcohol consumption	305 (49)
Comorbidities
CAD	89 (9.3)
Hypertension	669 (69.8)
Dyslipidemia	303 (31.6)
Obesity	202 (21.1)
Fibrosis score	6.9 (5.4-9.8)
CAP score, mean ± SD	222.86 ± 52.29
Steatosis severity1
S0	630 (69.7)
S1	56 (6.2)
S2	79 (8.7)
S3	139 (15.4)
Fibrosis assessment
F0-F1	500 (52.1)
F2	212 (22)
F3	71 (7.4)
F4	177 (18.5)
Labs
AST (IU/L)	30 (21-49)
ALT (IU/L)	16 (25-43)
HbA1c (%), mean ± SD	6.58 ± 1.92
Total bilirubin (mg/dL)	0.6 (0.4-0.8)
Platelet (103 /μL), mean ± SD	219.64 ± 84.68
Albumin (g/dL)	4.06 ± 0.45

¹Denominator for steatosis severity is 904 as 55 patients did not have complete controlled attenuation parameter scores.

BMI: Body mass index; CAD: Coronary artery disease; CAP: Controlled attenuation parameter; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; HBA1c: Hemoglobin A1C.